Skip to navigation Skip to content

Commercial Research Funding

Share

Commercial R&D Funding



Through Fast Forward, we are making high-impact early-stage investments to accelerate commercial Research and Development for new therapies and diagnostics for MS.

As a driving force of MS research to find pathways to a cure, the National MS Society takes a unique, comprehensive approach to funding research efforts. Since 2008 the National MS Society, through Fast Forward, has been driving the development of new therapies and diagnostics for people living with MS. Fast Forward  bridges the preclinical commercial funding gap, targets funds to de-risk therapeutic development and catalyzes further commercial investment.

Therapeutic Development Opportunities for Neuroprotection and Neuroregeneration in Multiple Sclerosis

Details on the current funding opportunity are available to download below. To submit a proposal for Fast Forward support, applicants must first register with our online portal (https://nmss.fluxx.io) and complete a brief pre-application. Staff will review the pre-application to determine whether the proposed research plan is appropriate and relevant to the objectives of the Request for Proposals (RFP).

Important dates:
Pre-applications will be accepted beginning October 24th, 2018
Final date for acceptance of pre-applications: December 5th, 2018
Final date for receipt of completed full applications: December 19th, 2018 

Additional information:  
For more information, please contact:

Mark Allegretta PhD    
Vice President, Research
mark.allegretta@nmss.org
212-476-0459
        
Maya Merrell
Director, Business and Partnership Development
maya.merrell@nmss.org
212-476-0443
        
Walter Kostich PhD    
Director, Commercial Research
walter.kostich@nmss.org
212-476-0428

Share